{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:30:46Z","timestamp":1775838646413,"version":"3.50.1"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BTM-ORG\/29580\/2017 DOI 10.54499\/UIDB\/04462\/2020 DOI 10.54499\/UIDP\/04462\/2020 DOI 10.54499\/LA\/P\/0087\/2020 UI\/BD\/151253\/2021 2022.11494.BD."],"award-info":[{"award-number":["PTDC\/BTM-ORG\/29580\/2017 DOI 10.54499\/UIDB\/04462\/2020 DOI 10.54499\/UIDP\/04462\/2020 DOI 10.54499\/LA\/P\/0087\/2020 UI\/BD\/151253\/2021 2022.11494.BD."]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Engineered 3D models employing human induced pluripotent stem cell (hiPSC) derivatives have the potential to recapitulate the cell diversity and structure found in the human central nervous system (CNS). Therefore, these complex cellular systems offer promising human models to address the safety and potency of advanced therapy medicinal products (ATMPs), such as gene therapies. Specifically, recombinant adeno-associated viruses (rAAVs) are currently considered highly attractive for CNS gene therapy due to their broad tropism, low toxicity, and moderate immunogenicity. To accelerate the clinical translation of rAAVs, in-depth preclinical evaluation of efficacy and safety in a human setting is primordial. The integration of hiPSC-derived CNS models in rAAV development will require, amongst other factors, robust, small-scale, high-throughput culture platforms that can feed the preclinical trials.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Herein, we pioneer the miniaturization and parallelization of a 200\u00a0mL stirred-tank bioreactor-based 3D brain cell culture derived from hiPSCs. We demonstrate the applicability of the automated miniaturized Ambr<jats:sup>\u00ae<\/jats:sup> 15 Cell Culture system for the maintenance of hiPSC-derived neurospheroids (iNSpheroids), composed of neuronal and glial cells. Critical process parameters were optimized, namely, cell density and agitation mode.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Under optimized conditions, stable iNSpheroid cultures were attained in the microbioreactors for at least 15\u00a0days, with high cell viability and astrocytic and neuronal phenotype maintenance. This culture setup allowed the parallelization of different rAAVs, in different multiplicity of infections (MOIs), to address rAAV-host interactions at a preclinical scale. The iNSpheroids were exposed to rAAV2- and rAAV9-eGFP in the microbioreactors. Transgene expression was detected 14\u00a0days post-transduction, revealing different astrocyte\/neuron tropism of the two serotypes.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> We advocate that the iNSpheroid cultures in miniaturized bioreactors are reliable and reproducible screening tools for addressing rAAV transduction and tropism, compatible with preclinical demands.<\/jats:p>","DOI":"10.3389\/fbioe.2024.1379597","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T05:02:28Z","timestamp":1714107748000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Miniaturization of hiPSC-derived 3D neural cultures in stirred-tank bioreactors for parallelized preclinical assessment of rAAV"],"prefix":"10.3389","volume":"12","author":[{"given":"Catarina M.","family":"Gomes","sequence":"first","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[]},{"given":"Gabriela","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Moura","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Sim\u00e3o","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Gomes-Alves","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Brito","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5607\/EN21013","article-title":"Adenovirus-induced reactive astrogliosis exacerbates the pathology of Parkinson\u2019s disease","volume":"30","author":"An","year":"2021","journal-title":"Exp. Neurobiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/MT.2011.287","article-title":"The AAV vector toolkit: poised at the clinical crossroads","volume":"20","author":"Asokan","year":"2012","journal-title":"Mol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","article-title":"Engineering the next generation of cell-based therapeutics","volume":"21","author":"Bashor","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B4","doi-asserted-by":"publisher","first-page":"16644","DOI":"10.1038\/s41598-018-34523-3","article-title":"Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons","volume":"8","author":"Bay\u00f3-Puxan","year":"2018","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/BIOENGINEERING7030115","article-title":"Innovative human three-dimensional tissue-engineered models as an alternative to animal testing","volume":"7","author":"B\u00e9dard","year":"2020","journal-title":"Bioengineering"},{"key":"B6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/J.TIBTECH.2010.12.001","article-title":"High-throughput process development for biopharmaceutical drug substances","volume":"29","author":"Bhambure","year":"2011","journal-title":"Trends Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/J.YMETH.2012.03.005","article-title":"Generation and genetic modification of 3D cultures of human dopaminergic neurons derived from neural progenitor cells","volume":"56","author":"Brito","year":"2012","journal-title":"Methods"},{"key":"B8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/NBT.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/J.OMTM.2017.11.007","article-title":"Emerging issues in AAV-mediated in vivo gene therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-021-09674-1","article-title":"Autocrine S100B in astrocytes promotes VEGF-dependent inflammation and oxidative stress and causes impaired neuroprotection","volume":"1","author":"Ding","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/BIT.28394","article-title":"Towards a scalable bioprocess for rAAV production using a HeLa stable cell line","volume":"120","author":"Escandell","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"B12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/BTPR.64","article-title":"293 cell cycle synchronisation adenovirus vector production","volume":"25","author":"Ferreira","year":"2009","journal-title":"Biotechnol. Prog."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1038\/s41598-021-81633-6","article-title":"High-throughput microbioreactor provides a capable tool for early stage bioprocess development","volume":"11","author":"Fink","year":"2021","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1089\/HUM.2011.053","article-title":"Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing \u03b11-antitrypsin: interim results","volume":"22","author":"Flotte","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"462744","DOI":"10.1016\/J.CHROMA.2021.462744","article-title":"Leveraging high-throughput purification to accelerate viral vector process development","volume":"1663","author":"Fu","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e2811","DOI":"10.1002\/BTPR.2811","article-title":"Development of a novel, high\u2010throughput screening tool for efficient perfusion\u2010based cell culture process development","volume":"35","author":"Gagliardi","year":"2019","journal-title":"Biotechnol. Prog."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1089\/HUM.2018.027","article-title":"Assessment of AAV vector tropisms for mouse and human pluripotent stem cell\u2013derived RPE and photoreceptor cells","volume":"29","author":"Gonzalez-Cordero","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/GT.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1753-6561-9-S9-P15","article-title":"Media optimization for CHO fed-batch processes using a DoE approach in automated high-throughput single use ambr15 bioreactors","volume":"99","author":"Grimm","year":"2015","journal-title":"BMC Proc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/J.NEUROSCIENCE.2021.12.015","article-title":"Akt\/Aquaporin-4 signaling aggravates neuropathic pain by activating astrocytes after spinal nerve ligation in rats","volume":"482","author":"Guo","year":"2022","journal-title":"Neuroscience"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0188830","DOI":"10.1371\/JOURNAL.PONE.0188830","article-title":"Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection","volume":"12","author":"Hammond","year":"2017","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/J.VIROL.2007.10.007","article-title":"Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro","volume":"372","author":"Howard","year":"2008","journal-title":"Virology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15029","DOI":"10.1038\/MTM.2015.29","article-title":"AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes","volume":"2","author":"Hui","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1205\/CERD.82.9.1082.44161","article-title":"Suspension of microcarriers for cell culture with axial flow impellers","volume":"82","author":"Ibrahim","year":"2004","journal-title":"Chem. Eng. Res. Des."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e3277","DOI":"10.1002\/BTPR.3277","article-title":"Application of Ambr15 system for simulation of entire SARS-CoV-2 vaccine production process involving macrocarriers","volume":"38","author":"Jayson","year":"2022","journal-title":"Biotechnol. Prog."},{"key":"B26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/J.ADDR.2020.09.012","article-title":"Engineered tissues and strategies to overcome challenges in drug development","volume":"158","author":"Khalil","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/J.STEM.2021.03.004","article-title":"Organoid modeling of Zika and herpes simplex virus 1 infections reveals virus-specific responses leading to microcephaly","volume":"28","author":"Krenn","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","article-title":"Generation of cerebral organoids from human pluripotent stem cells","volume":"910","author":"Lancaster","year":"2014","journal-title":"Nat. Protoc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"108304","DOI":"10.1016\/J.BEJ.2021.108304","article-title":"MRI hydrodynamic characterization of an ambr15\u00ae bioreactor","volume":"179","author":"Legrand","year":"2022","journal-title":"Biochem. Eng. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1056\/nejmra1806175","article-title":"Organoids \u2014 preclinical models of human disease","volume":"380","author":"Li","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/NATURE21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.omtm.2022.05.008","article-title":"Application of in-vitro-cultured primary hepatocytes to evaluate species translatability and AAV transduction mechanisms of action","volume":"26","author":"Liu","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"123","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/mt.2009.286","article-title":"Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain","volume":"18","author":"Markakis","year":"2010","journal-title":"Mol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2157-7412.S1-009","article-title":"Liver-directed adeno-associated viral gene therapy for hemophilia","volume":"1","author":"Markusic","year":"2013","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902018000001006","article-title":"Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD)","volume":"54","author":"Martins Fukuda","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/HEP.32733","article-title":"Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy","volume":"77","author":"Meumann","year":"2023","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8+ T-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"Mingozzi","year":"2007","journal-title":"Nat. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins","volume":"19","author":"Nathwani","year":"2011","journal-title":"Mol. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.3390\/IJMS19113544","article-title":"Immunohistochemical evaluation of aquaporin-4 and its correlation with CD68, IBA-1, HIF-1\u03b1, GFAP, and CD15 expressions in fatal traumatic brain injury","volume":"19","author":"Neri","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1016\/S0009-2509(97)00072-9","article-title":"On impeller circulation and mixing effectiveness in the turbulent flow regime","volume":"52","author":"Nienow","year":"1997","journal-title":"Chem. Eng. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/FNMOL.2020.618020\/BIBTEX","article-title":"AAV targeting of glial cell types in the central and peripheral nervous system and relevance to human gene therapy","volume":"13","author":"O\u2019Carroll","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12974-023-02728-7","article-title":"Helicobacter pylori outer membrane vesicles induce astrocyte reactivity through nuclear factor-\u03baappa B activation and cause neuronal damage in vivo in a murine model","volume":"20","author":"Palacios","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0133607","DOI":"10.1371\/JOURNAL.PONE.0133607","article-title":"Transcriptional response of human neurospheres to helper-dependent CAV-2 vectors involves the modulation of DNA damage response, microtubule and centromere gene groups","volume":"10","author":"Piersanti","year":"2015","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/BIT.26359","article-title":"Process development of human multipotent stromal cell microcarrier culture using an automated high-throughput microbioreactor","volume":"114","author":"Rafiq","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"B47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4155\/PBP.14.63","article-title":"Cell therapies: why scale matters","volume":"3","author":"Rafiq","year":"2015","journal-title":"Pharm. Bioprocess"},{"key":"B48","doi-asserted-by":"publisher","first-page":"753467","DOI":"10.3389\/FIMMU.2021.753467","article-title":"Adeno-associated viruses (AAV) and host immunity \u2013 a race between the hare and the hedgehog","volume":"12","author":"Rapti","year":"2021","journal-title":"Front. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e52904","DOI":"10.7554\/ELIFE.52904","article-title":"A fully automated high-throughput workflow for 3d-based chemical screening in human midbrain organoids","volume":"9","author":"Renner","year":"2020","journal-title":"Elife"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0283429","DOI":"10.1371\/JOURNAL.PONE.0283429","article-title":"Astrocytes derived from neural progenitor cells are susceptible to Zika virus infection","volume":"18","author":"Rubio-Hern\u00e1ndez","year":"2023","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"97","author":"Schindelin","year":"2012","journal-title":"Nat. Methods 2012"},{"key":"B52","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/BIOT.201400765","article-title":"Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions","volume":"10","author":"Silva","year":"2015","journal-title":"Biotechnol. J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/7651_2016_333","article-title":"Perfusion stirred-tank bioreactors for 3D differentiation of human neural stem cells","volume":"1502","author":"Sim\u00e3o","year":"","journal-title":"Methods Mol. Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/gt.2015.75","article-title":"Evaluation of helper-dependent canine adenovirus vectors in a 3D human CNS model","volume":"23","author":"Sim\u00e3o","year":"","journal-title":"Gene Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.stemcr.2018.06.020","article-title":"Recapitulation of human neural microenvironment signatures in iPSC-derived NPC 3D differentiation","volume":"11","author":"Sim\u00e3o","year":"2018","journal-title":"Stem Cell Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.coviro.2016.08.003","article-title":"In vivo tissue-tropism of adeno-associated viral vectors","volume":"21","author":"Srivastava","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/IJMS13010427","article-title":"Adaptation of high-throughput screening in drug discovery-toxicological screening tests","volume":"13","author":"Szyma\u0144ski","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","article-title":"Human organoids in basic research and clinical applications","volume":"71","author":"Tang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/BTPR.2575","article-title":"Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro-bioreactor system","volume":"34","author":"Velugula-Yellela","year":"2018","journal-title":"Biotechnol. Prog."},{"key":"B60","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B61","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/HUM.2022.188","article-title":"Assessment of pre-clinical liver models based on their ability to predict the liver-tropism of adeno-associated virus vectors","volume":"34","author":"Westhaus","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ELSC.202100172","article-title":"Optimization of a mAb production process with regard to robustness and product quality using quality by design principles","volume":"22","author":"Wohlenberg","year":"2022","journal-title":"Eng. Life Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5607\/en.2017.26.3.158","article-title":"Functional characterization of resting and adenovirus-induced reactive astrocytes in three-dimensional culture","volume":"26","author":"Woo","year":"2017","journal-title":"Exp. Neurobiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/J.CELL.2022.11.030","article-title":"SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming","volume":"186","author":"Wu","year":"2023","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41422-019-0152-9","article-title":"Zika virus infection induces RNAi-mediated antiviral immunity in human neural progenitors and brain organoids","volume":"29","author":"Xu","year":"2019","journal-title":"Cell Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.4103\/1673-5374.369100","article-title":"The generation and properties of human cortical organoids as a disease model for malformations of cortical development","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.7150\/THNO.80271","article-title":"Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson\u2019s disease","volume":"13","author":"Zheng","year":"2023","journal-title":"Theranostics"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1379597\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T05:02:33Z","timestamp":1714107753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1379597\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":67,"alternative-id":["10.3389\/fbioe.2024.1379597"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2024.1379597","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]},"article-number":"1379597"}}